In mouse models of AD-like skin inflammation induced by epicutaneous exposure to Staphylococcus aureus, treatment with anti-IL-36R-blocking antibodies suppressed release of IL-36α by KCs, IL-4 triggered B cell IgE class-switching, plasma cell differentiation, and increased serum IgE levels [63]. The gene discussed is IL4; the disease is Alzheimer disease.